Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

MESP1 antibody (N-Term)

This anti-MESP1 antibody is a Rabbit Polyclonal antibody detecting MESP1 in WB, ELISA and IHC. Suitable for Human.
Catalog No. ABIN2316333

Quick Overview for MESP1 antibody (N-Term) (ABIN2316333)

Target

See all MESP1 Antibodies
MESP1 (Mesoderm Posterior 1 (MESP1))

Reactivity

  • 25
  • 12
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 33
  • 3
Rabbit

Clonality

  • 33
  • 3
Polyclonal

Conjugate

  • 24
  • 4
  • 2
  • 2
  • 2
  • 2
This MESP1 antibody is un-conjugated

Application

  • 33
  • 22
  • 12
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
  • Binding Specificity

    • 11
    • 7
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 46-75, N-Term

    Cross-Reactivity

    Human

    Cross-Reactivity (Details)

    Calculated cross reactivity: Hu

    Characteristics

    MESP1, NT (MESP1, BHLHC5, Mesoderm posterior protein 1, Class C basic helix-loop-helix protein 5)

    Purification

    Purified by Protein A affinity chromatography.

    Immunogen

    KLH-conjugated synthetic peptide mapping to a fragment of residues within amino acids 46-75 in the N-terminal region of human MESP1, UniProt Accession #Q9BRJ9.

    Isotype

    IgG
  • Application Notes

    Optimal working conditions should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C

    Storage Comment

    -20°C
  • Target

    MESP1 (Mesoderm Posterior 1 (MESP1))

    Alternative Name

    MESP1

    NCBI Accession

    NP_061140

    UniProt

    Q9BRJ9

    Pathways

    Regulation of Muscle Cell Differentiation
You are here:
Chat with us!